search
Back to results

Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

Primary Purpose

Joint Diseases, Joint Pain

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
SSNB + IPACK
FNB + IPACK
Sponsored by
Luzerner Kantonsspital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Joint Diseases focused on measuring Subsartorial Saphenous Nerve Block (SSNB), Femoral Nerve Block (FNB), Total Knee Arthroplasty (TKA)

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: age > 18yrs primary TKA BMI 35kg/m2 or less able to give informed consent as documented by signature clinical history without any contraindications for the planned intervention Exclusion criteria: age < 18 years revision-TKA BMI >35kg/m2 absent contact information inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases pregnancy inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc. withdrawal from the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Intervention group: SSNB + IPACK (group 1)

    Control group: FNB + IPACK (group 2)

    Arm Description

    Subsartorial Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: proximal adductor channel, intersection of the medial borders of the sartorius muscle and the adductor longus, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation

    Femoral Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: lateral to the femoral artery,level of the femoral crease (proximal to the vascular outlet of the deep artery of the thigh), femoral nerve lies on the surface of the iliopsoas muscle and is covered by the fascia iliaca, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation

    Outcomes

    Primary Outcome Measures

    Functional muscle power output of the leg
    Cycle sprint test measuring maximum lower limb muscle power in Watts (W) from 3 times 10-second maximal efforts (higher values better)

    Secondary Outcome Measures

    Muscle strength
    Manual muscle testing (MMT) as a standardized measuring tool to assess quadriceps muscle strength using a numeric score 0-5 (Daniels and Worthingham Scale): patient in sitting position in 20 degree knee flexion is asked to extend the knee actively against resistance proximal to the ankle (higher values better)
    Mobility
    Timed up and go test (TUG): standardized measuring tool, the patient is timed while they rise from an arm chair (approximate seat height 46 cm), walk at a comfortable and safe pace to a line on the floor 3 metres away, turn and walk back to the chair and sit down again (in seconds) (lower values better)
    Clinical results
    redness, swelling, hyperthermia, wound/scar, range of motion, stability, adverse events
    Radiological results
    x-rays ap and lateral view(1), patella(2), whole leg axis(3)
    Pain control
    numeric rating scale 0-10 (lower values better)
    Opioid consumption
    documentation of administered drugs including name of drug, dosage, frequency of use
    Length of hospital stay
    documentation of days in hospital
    Patient satisfaction 1
    Questionnaire (Oxford Knee Score) 12-60 points (lower values better)
    Patient satisfaction 2
    Questionnaire (EQ-5D-5L) 5 questions with 5 answers each (lower values better) including EQ-VAS 0-100 (higher values better)

    Full Information

    First Posted
    August 23, 2023
    Last Updated
    October 3, 2023
    Sponsor
    Luzerner Kantonsspital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06074744
    Brief Title
    Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
    Official Title
    Subsartorial Saphenous Nerve Block (SSNB) Versus Femoral Nerve Block (FNB) in Primary Total Knee Arthroplasty (TKA) Combined With Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK) - Where Are the Benefits?
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 2023 (Anticipated)
    Primary Completion Date
    December 2026 (Anticipated)
    Study Completion Date
    December 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Luzerner Kantonsspital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: - is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : functional muscle power output of the leg? muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?
    Detailed Description
    Prospective, randomized, double-blinded, single-center, controlled clinical trial with intervention group (SSNB + IPACK, group 1) and control group (FNB + IPACK, group 2), randomization by sealed envelopes. The number of participants will be 72 per group, calculated based on a sample size calculator program. The 3 surgeons will be blinded as well as the patients regarding the nerve block they will receive. We will explain to the patients how both the blocks will be carried out, that 1 block will be located "higher on the leg" and 1 "lower on the leg". The nerve blocks will be carried out by a well-trained anaesthesiologist following standard procedures preoperative. The IPACK will be applied by the surgeons intraoperative, following a standard protocol. The used implant for all patients will be the cemented ATTUNE™ Primary Knee System® (DePuySynthes Johnson&Johnson). Every patient will wear a brace fixed in full extension after surgery for the first 24 hours. Postoperative all patients will receive a standard set of adequate analgesics. The postoperative rehabilitation program will follow our well-established physiotherapy scheme. Performed assessments: Range of motion (ROM) medical history physical examinations radiologic controls adverse events falls during hospital stay (standard protocol) pain assessment (numeric rating scale) Questionnaires (EQ-5D-5L und Oxford Knee Score) will be filled in by the patients Functional assessment: Cycle sprint test one a specially instrumented indoor bike (Verve Info Tec PTY LTD) fit with an instrumented crank (InfoCrank Power Meter, Verve Cycling, West Perth, Australia) Functional assessment: Manual muscle testing (MMT) Functional assessment: Timed up and go test (TUG) Superiority analysis using a two sample t-test, significance level 0.05, power 80%. Data will be stored electronically in the data base (RedCap). In case of missing data there will always be attempts to obtain these data afterwards (contacting the patients by phone). Further on statistical analysis is performed. Dropouts, before the 6 weeks follow-up, will be replaced by recruitment of new subjects. For quality assurance the sponsor, the Ethics Committee or an independent trial monitor may visit the research sites.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Joint Diseases, Joint Pain
    Keywords
    Subsartorial Saphenous Nerve Block (SSNB), Femoral Nerve Block (FNB), Total Knee Arthroplasty (TKA)

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Masking Description
    randomization by sealed envelopes
    Allocation
    Randomized
    Enrollment
    144 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Intervention group: SSNB + IPACK (group 1)
    Arm Type
    Active Comparator
    Arm Description
    Subsartorial Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: proximal adductor channel, intersection of the medial borders of the sartorius muscle and the adductor longus, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation
    Arm Title
    Control group: FNB + IPACK (group 2)
    Arm Type
    Active Comparator
    Arm Description
    Femoral Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: lateral to the femoral artery,level of the femoral crease (proximal to the vascular outlet of the deep artery of the thigh), femoral nerve lies on the surface of the iliopsoas muscle and is covered by the fascia iliaca, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation
    Intervention Type
    Other
    Intervention Name(s)
    SSNB + IPACK
    Other Intervention Name(s)
    Subsartorial Nerve Block
    Intervention Description
    already included in arm/group description
    Intervention Type
    Other
    Intervention Name(s)
    FNB + IPACK
    Other Intervention Name(s)
    Femoral Nerve Block
    Intervention Description
    already included in arm/group description
    Primary Outcome Measure Information:
    Title
    Functional muscle power output of the leg
    Description
    Cycle sprint test measuring maximum lower limb muscle power in Watts (W) from 3 times 10-second maximal efforts (higher values better)
    Time Frame
    preoperative, 6 weeks, 12 weeks, 1 year after surgery
    Secondary Outcome Measure Information:
    Title
    Muscle strength
    Description
    Manual muscle testing (MMT) as a standardized measuring tool to assess quadriceps muscle strength using a numeric score 0-5 (Daniels and Worthingham Scale): patient in sitting position in 20 degree knee flexion is asked to extend the knee actively against resistance proximal to the ankle (higher values better)
    Time Frame
    preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
    Title
    Mobility
    Description
    Timed up and go test (TUG): standardized measuring tool, the patient is timed while they rise from an arm chair (approximate seat height 46 cm), walk at a comfortable and safe pace to a line on the floor 3 metres away, turn and walk back to the chair and sit down again (in seconds) (lower values better)
    Time Frame
    preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks1 year after surgery
    Title
    Clinical results
    Description
    redness, swelling, hyperthermia, wound/scar, range of motion, stability, adverse events
    Time Frame
    preoperative, day of discharge (7+/- 2 days postoperative), 6, 12 weeks, 1 year after surgery
    Title
    Radiological results
    Description
    x-rays ap and lateral view(1), patella(2), whole leg axis(3)
    Time Frame
    preoperative(1-3), day 1 after surgery(1), 6 weeks(1-2), 1 year after surgery(1-3)
    Title
    Pain control
    Description
    numeric rating scale 0-10 (lower values better)
    Time Frame
    before surgery, twice daily on the ward (except first 6 hours: hourly), day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
    Title
    Opioid consumption
    Description
    documentation of administered drugs including name of drug, dosage, frequency of use
    Time Frame
    before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
    Title
    Length of hospital stay
    Description
    documentation of days in hospital
    Time Frame
    before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery
    Title
    Patient satisfaction 1
    Description
    Questionnaire (Oxford Knee Score) 12-60 points (lower values better)
    Time Frame
    preoperative, 6 weeks, 12 weeks, 1 year after surgery
    Title
    Patient satisfaction 2
    Description
    Questionnaire (EQ-5D-5L) 5 questions with 5 answers each (lower values better) including EQ-VAS 0-100 (higher values better)
    Time Frame
    preoperative, 6 weeks, 12 weeks, 1 year after surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion criteria: age > 18yrs primary TKA BMI 35kg/m2 or less able to give informed consent as documented by signature clinical history without any contraindications for the planned intervention Exclusion criteria: age < 18 years revision-TKA BMI >35kg/m2 absent contact information inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases pregnancy inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc. withdrawal from the study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Judith Bering, Dr. med.
    Phone
    +41 41 205 18 91
    Email
    judith.bering@luks.ch
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Judith Bering, Dr. med.
    Organizational Affiliation
    Luzerner Kantonsspital Luzern
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    Citation
    Declaration of Helsinki, Version October 2013
    Results Reference
    background
    Citation
    International Conference on Harmonization (ICH) E6(R2) Guideline for Good Clinical Practice
    Results Reference
    background
    Citation
    International Conference on Harmonization (ICH, 1997) E8 Guideline: General Considerations for Clinical Trials
    Results Reference
    background
    Citation
    Implantatregister SIRIS Hüfte und Knie: Kurzfassung - SIRIS Report 2022
    Results Reference
    background
    Citation
    Bundesamt für Statistik, Schweiz
    Results Reference
    background
    PubMed Identifier
    24201900
    Citation
    Grosu I, Lavand'homme P, Thienpont E. Pain after knee arthroplasty: an unresolved issue. Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1744-58. doi: 10.1007/s00167-013-2750-2. Epub 2013 Nov 8.
    Results Reference
    background
    Citation
    Burket LW, Greenberg MS, Glick M. Burkett's Textbook of Oral Medicine. 10th ed. Philadelphia, PA: Lippincott
    Results Reference
    background
    PubMed Identifier
    4796576
    Citation
    Winnie AP, Ramamurthy S, Durrani Z. The inguinal paravascular technic of lumbar plexus anesthesia: the "3-in-1 block". Anesth Analg. 1973 Nov-Dec;52(6):989-96. No abstract available.
    Results Reference
    background
    PubMed Identifier
    3664912
    Citation
    Tierney E, Lewis G, Hurtig JB, Johnson D. Femoral nerve block with bupivacaine 0.25 per cent for postoperative analgesia after open knee surgery. Can J Anaesth. 1987 Sep;34(5):455-8. doi: 10.1007/BF03014348.
    Results Reference
    background
    PubMed Identifier
    7190803
    Citation
    Rosenblatt RM. Continuous femoral anesthesia for lower extremity surgery. Anesth Analg. 1980 Aug;59(8):631-2. No abstract available.
    Results Reference
    background
    PubMed Identifier
    1632541
    Citation
    Edwards ND, Wright EM. Continuous low-dose 3-in-1 nerve blockade for postoperative pain relief after total knee replacement. Anesth Analg. 1992 Aug;75(2):265-7. doi: 10.1213/00000539-199208000-00020.
    Results Reference
    background
    PubMed Identifier
    32093655
    Citation
    Ma HH, Chou TA, Tsai SW, Chen CF, Wu PK, Chen WM. The efficacy of continuous versus single-injection femoral nerve block in Total knee Arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020 Feb 24;21(1):121. doi: 10.1186/s12891-020-3148-1.
    Results Reference
    background
    PubMed Identifier
    19126912
    Citation
    Atkinson HD, Hamid I, Gupte CM, Russell RC, Handy JM. Postoperative fall after the use of the 3-in-1 femoral nerve block for knee surgery: a report of four cases. J Orthop Surg (Hong Kong). 2008 Dec;16(3):381-4. doi: 10.1177/230949900801600324.
    Results Reference
    background
    PubMed Identifier
    19680735
    Citation
    Sharma S, Iorio R, Specht LM, Davies-Lepie S, Healy WL. Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468(1):135-40. doi: 10.1007/s11999-009-1025-1. Epub 2009 Aug 13.
    Results Reference
    background
    PubMed Identifier
    19553071
    Citation
    Feibel RJ, Dervin GF, Kim PR, Beaule PE. Major complications associated with femoral nerve catheters for knee arthroplasty: a word of caution. J Arthroplasty. 2009 Sep;24(6 Suppl):132-7. doi: 10.1016/j.arth.2009.04.008. Epub 2009 Jun 24.
    Results Reference
    background
    PubMed Identifier
    30276220
    Citation
    Runner RP, Boden SA, Godfrey WS, Premkumar A, Samady H, Gottschalk MB, Xerogeanes JW. Quadriceps Strength Deficits After a Femoral Nerve Block Versus Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective, Single-Blinded, Randomized Trial. Orthop J Sports Med. 2018 Sep 26;6(9):2325967118797990. doi: 10.1177/2325967118797990. eCollection 2018 Sep.
    Results Reference
    background
    PubMed Identifier
    25466410
    Citation
    Luo TD, Ashraf A, Dahm DL, Stuart MJ, McIntosh AL. Femoral nerve block is associated with persistent strength deficits at 6 months after anterior cruciate ligament reconstruction in pediatric and adolescent patients. Am J Sports Med. 2015 Feb;43(2):331-6. doi: 10.1177/0363546514559823. Epub 2014 Dec 2.
    Results Reference
    background
    PubMed Identifier
    31317214
    Citation
    Everhart JS, Hughes L, Abouljoud MM, Swank K, Lewis C, Flanigan DC. Femoral nerve block at time of ACL reconstruction causes lasting quadriceps strength deficits and may increase short-term risk of re-injury. Knee Surg Sports Traumatol Arthrosc. 2020 Jun;28(6):1894-1900. doi: 10.1007/s00167-019-05628-7. Epub 2019 Jul 17.
    Results Reference
    background
    PubMed Identifier
    17377115
    Citation
    Brull R, McCartney CJ, Chan VW, El-Beheiry H. Neurological complications after regional anesthesia: contemporary estimates of risk. Anesth Analg. 2007 Apr;104(4):965-74. doi: 10.1213/01.ane.0000258740.17193.ec.
    Results Reference
    background
    PubMed Identifier
    8403121
    Citation
    van der Wal M, Lang SA, Yip RW. Transsartorial approach for saphenous nerve block. Can J Anaesth. 1993 Jun;40(6):542-6. doi: 10.1007/BF03009739.
    Results Reference
    background
    PubMed Identifier
    8398966
    Citation
    Mansour NY. Sub-sartorial saphenous nerve block with the aid of nerve stimulator. Reg Anesth. 1993 Jul-Aug;18(4):266-8. No abstract available.
    Results Reference
    background
    PubMed Identifier
    26938989
    Citation
    Abdallah FW, Whelan DB, Chan VW, Prasad GA, Endersby RV, Theodoropolous J, Oldfield S, Oh J, Brull R. Adductor Canal Block Provides Noninferior Analgesia and Superior Quadriceps Strength Compared with Femoral Nerve Block in Anterior Cruciate Ligament Reconstruction. Anesthesiology. 2016 May;124(5):1053-64. doi: 10.1097/ALN.0000000000001045.
    Results Reference
    background
    Citation
    Maye A, Hurley E, Jamal M, Curley G. Adductor canal block versus femoral nerve block in total knee arthroplasty: a Meta-Analysis of randomized control trials. ESRA 2019 19-0449
    Results Reference
    background
    PubMed Identifier
    36673579
    Citation
    Fan Chiang YH, Wang MT, Chan SM, Chen SY, Wang ML, Hou JD, Tsai HC, Lin JA. Motor-Sparing Effect of Adductor Canal Block for Knee Analgesia: An Updated Review and a Subgroup Analysis of Randomized Controlled Trials Based on a Corrected Classification System. Healthcare (Basel). 2023 Jan 10;11(2):210. doi: 10.3390/healthcare11020210.
    Results Reference
    background
    PubMed Identifier
    36042669
    Citation
    Hasabo EA, Assar A, Mahmoud MM, Abdalrahman HA, Ibrahim EA, Hasanin MA, Emam AK, AbdelQadir YH, AbdelAzim AA, Ali AS. Adductor canal block versus femoral nerve block for pain control after total knee arthroplasty: A systematic review and Meta-analysis. Medicine (Baltimore). 2022 Aug 26;101(34):e30110. doi: 10.1097/MD.0000000000030110.
    Results Reference
    background
    Citation
    Sinha S, Abras J, Sivasenthil D. Use of ultrasound guided popliteal fossa infiltration to control pain after total knee arthroplasty: a prospective randomized observer-blinded study. ASRA 37th Annual Regional Anesthesia Meeting and Workshops; March 15-18, San Diego, CA, 2012
    Results Reference
    background
    PubMed Identifier
    33990439
    Citation
    Chan E, Howle R, Onwochei D, Desai N. Infiltration between the popliteal artery and the capsule of the knee (IPACK) block in knee surgery: a narrative review. Reg Anesth Pain Med. 2021 Sep;46(9):784-805. doi: 10.1136/rapm-2021-102681. Epub 2021 May 14.
    Results Reference
    background
    PubMed Identifier
    35962410
    Citation
    Guo J, Hou M, Shi G, Bai N, Huo M. iPACK block (local anesthetic infiltration of the interspace between the popliteal artery and the posterior knee capsule) added to the adductor canal blocks versus the adductor canal blocks in the pain management after total knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2022 Aug 12;17(1):387. doi: 10.1186/s13018-022-03272-5.
    Results Reference
    background
    PubMed Identifier
    34653576
    Citation
    Mou P, Wang D, Tang XM, Zeng WN, Zeng Y, Yang J, Zhou ZK. Adductor Canal Block Combined With IPACK Block for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. J Arthroplasty. 2022 Feb;37(2):259-266. doi: 10.1016/j.arth.2021.10.004. Epub 2021 Oct 13.
    Results Reference
    background
    PubMed Identifier
    34189216
    Citation
    Hurworth M, Evans JM, Gibbons R, Mackie KE, Edmondston SJ. Cycle Sprint Test for the Evaluation of Lower Limb Muscle Power After Total Knee Arthroplasty: A Proof-of-Concept Study. Arthroplast Today. 2021 Jun 15;9:118-121. doi: 10.1016/j.artd.2021.05.007. eCollection 2021 Jun.
    Results Reference
    background
    Citation
    Wright, W. Muscle training in the treatment of infantile paralysis. Boston Med. Surg. J. 1912, 167, 567-574
    Results Reference
    background
    PubMed Identifier
    32680754
    Citation
    Li D, Alqwbani M, Wang Q, Liao R, Yang J, Kang P. Efficacy of Adductor Canal Block Combined With Additional Analgesic Methods for Postoperative Analgesia in Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. J Arthroplasty. 2020 Dec;35(12):3554-3562. doi: 10.1016/j.arth.2020.06.060. Epub 2020 Jun 24.
    Results Reference
    background
    PubMed Identifier
    22588746
    Citation
    Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S208-28. doi: 10.1002/acr.20632. No abstract available.
    Results Reference
    background
    Citation
    EQ-5D-3L Manual Guide. Euroquol.org. 2021 [cited 28 March 2021]. vailable from: https://euroquol.org/wp-content/uploads/2019/10/EQ-5D-3L-User-Guide_version-6.0.pd
    Results Reference
    background
    PubMed Identifier
    34922564
    Citation
    Lam CLK, Tse ETY, Wong CKH, Lam JSM, Chen SS, Bedford LE, Cheung JPY, Or CK, Kind P. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice. Health Qual Life Outcomes. 2021 Dec 18;19(1):266. doi: 10.1186/s12955-021-01898-3.
    Results Reference
    background
    PubMed Identifier
    36728455
    Citation
    Stocks GW, Odoemene M, Gex J, Vidal EA, Sawyer K, Jones SL, Thompson B, Laughlin MS. Quadriceps Strain and TKA: Contribution of the Tourniquet and Intramedullary Rod to Postoperative Thigh Pain: A Randomized Controlled Trial. J Bone Joint Surg Am. 2023 Mar 15;105(6):455-461. doi: 10.2106/JBJS.22.00703. Epub 2023 Jan 9.
    Results Reference
    background
    PubMed Identifier
    1991946
    Citation
    Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. doi: 10.1111/j.1532-5415.1991.tb01616.x.
    Results Reference
    background
    PubMed Identifier
    24484314
    Citation
    Barry E, Galvin R, Keogh C, Horgan F, Fahey T. Is the Timed Up and Go test a useful predictor of risk of falls in community dwelling older adults: a systematic review and meta-analysis. BMC Geriatr. 2014 Feb 1;14:14. doi: 10.1186/1471-2318-14-14.
    Results Reference
    background
    PubMed Identifier
    10960937
    Citation
    Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.
    Results Reference
    background
    Citation
    Common Terminology Criteria for Adverse Events (CTCAE) https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
    Results Reference
    background
    Citation
    Federal Act on Data Protection (FADP) https://www.admin.ch/opc/en/classified-compilation/19920153/index.html
    Results Reference
    background
    Citation
    Human Research Act (HRA) https://www.admin.ch/opc/de/classified-compilation/20061313/index.html
    Results Reference
    background
    Citation
    International Conference on Harmonization (ICH) E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002749.pdf
    Results Reference
    background
    Citation
    Ordinance on Clinical Trials in Human Research (ClinO) https://www.admin.ch/opc/de/classified-compilation/20121176/index.html
    Results Reference
    background

    Learn more about this trial

    Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

    We'll reach out to this number within 24 hrs